4.5 Article

Development of thioquinazolinones, allosteric Chk1 kinase inhibitors

期刊

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
卷 19, 期 4, 页码 1240-1244

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2008.12.076

关键词

Chk1; Thioquinazolinone; Allosteric kinase inhibitor; X-ray crystal structure

向作者/读者索取更多资源

A high throughput screening campaign was designed to identify allosteric inhibitors of Chk1 kinase by testing compounds at high concentration. Activity was then observed at K-m for ATP and at near-physiological concentrations of ATP. This strategy led to the discovery of a non-ATP competitive thioquinazolinone series which was optimized for potency and stability. An X-ray crystal structure for the complex of our best inhibitor bound to Chk1 was solved, indicating that it binds to an allosteric site similar to 13 angstrom from the ATP binding site. Preliminary data is presented for several of these compounds. (C) 2009 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemical Research Methods

Algorithms for the automated selection of fragment-like molecules using single-point surface plasmon resonance measurements

Constantine Kreatsoulas, Kartik Narayan

ANALYTICAL BIOCHEMISTRY (2010)

Article Chemistry, Medicinal

Identification of potent, highly constrained CGRP receptor antagonists

Craig A. Stump, Ian M. Bell, Rodney A. Bednar, John F. Fay, Steven N. Gallicchio, James C. Hershey, Richard Jelley, Constantine Kreatsoulas, Eric L. Moore, Scott D. Mosser, Amy G. Quigley, Shane A. Roller, Christopher A. Salvatore, Steven S. Sharik, Cory R. Theberge, C. Blair Zartman, Stefanie A. Kane, Samuel L. Graham, Harold G. Selnick, Joseph P. Vacca, Theresa M. Williams

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)

Article Chemistry, Medicinal

Pyridyl aminothiazoles as potent inhibitors of Chk1 with slow dissociation rates

Vadim Y. Dudkin, Keith Rickert, Constantine Kreatsoulas, Cheng Wang, Kenneth L. Arrington, Mark E. Fraley, George D. Hartman, Yowei Yan, Mari Ikuta, Steven M. Stirdivant, Robert A. Drakas, Eileen S. Walsh, Kelly Hamilton, Carolyn A. Buser, Robert B. Lobell, Laura Sepp-Lorenzino

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)

Article Pharmacology & Pharmacy

The M1 Muscarinic Receptor Allosteric Agonists AC-42 and 1-[1′-(2-Methylbenzyl)-1,4′-bipiperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one Bind to a Unique Site Distinct from the Acetylcholine Orthosteric Site

Marlene A. Jacobson, Constantine Kreatsoulas, Danette M. Pascarella, Julie A. O'Brien, Cyrille Sur

MOLECULAR PHARMACOLOGY (2010)

Article Multidisciplinary Sciences

Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation

Lei Ma, Matthew Seager, Marion Wittmann, Marlene Jacobson, Denise Bickel, Maryann Burno, Keith Jones, Valerie Kuzmick Graufelds, Guangping Xu, Michelle Pearson, Alexander McCampbell, Renee Gaspar, Paul Shughrue, Andrew Danziger, Christopher Regan, Rose Flick, Danette Pascarella, Susan Garson, Scott Doran, Constantine Kreatsoulas, Lone Veng, Craig W. Lindsley, William Shipe, Scott Kuduk, Cyrille Sur, Gene Kinney, Guy R. Seabrook, William J. Ray

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Chemistry, Medicinal

Fragment-Based Discovery of 6-Azaindazoles As Inhibitors of Bacterial DNA Ligase

Steven Howard, Nader Amin, Andrew B. Benowitz, Elisabetta Chiarparin, Haifeng Cui, Xiaodong Deng, Tom D. Heightman, David J. Holmes, Anna Hopkins, Jianzhong Huang, Qi Jin, Constantine Kreatsoulas, Agnes C. L. Martin, Frances Massey, Lynn McCloskey, Paul N. Mortenson, Puja Pathuri, Dominic Tisi, Pamela A. Williams

ACS MEDICINAL CHEMISTRY LETTERS (2013)

Article Chemistry, Medicinal

Scaffold-Based Analytics: Enabling Hit-to-Lead Decisions by Visualizing Chemical Series Linked across Large Datasets

Deepak Bandyopadhyay, Constantine Kreatsoulas, Pat G. Brady, Joseph Boyer, Zangdong He, Genaro Scavello, Tyler Peryea, Ajit Jadhav, Dac-Trung Nguyen, Rajarshi Guha

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2019)

Article Chemistry, Medicinal

Discovery of Pyrazolocarboxamides as Potent and Selective Receptor Interacting Protein 2 (RIP2) Kinase Inhibitors

Curt D. Haffner, Adam K. Charnley, Christopher J. Aquino, Linda Casillas, Maire A. Convery, Julie A. Cox, Mark A. Elban, Nicole C. Goodwin, Peter J. Gough, Pamela A. Haile, Terry V. Hughes, Beth Knapp-Reed, Constantine Kreatsoulas, Ami S. Lakdawala, Huijie Li, Yiqian Lian, David Lipshutz, John F. Mehlmann, Michael Ouellette, Joseph Romano, Lisa Shewchuk, Arthur Shu, Bartholomew J. Votta, Huiqiang Zhou, John Bertin, Robert W. Marquis

ACS MEDICINAL CHEMISTRY LETTERS (2019)

Article Chemistry, Medicinal

Synthesis and evaluation of substituted benzoisoquinolinones as potent inhibitors of Chk1 kinase

Robert M. Garbaccio, Shaei Huang, Edward S. Tasber, Mark E. Fraley, Youwei Yan, Sanjeev Munshi, Mari Ikuta, Lawrence Kuo, Constanine Kreatsoulas, Steve Stirdivant, Bob Drakas, Keith Rickert, Eileen S. Walsh, Kelly A. Hamilton, Carolyn A. Buser, James Hardwick, Xianzhi Mao, Stephen C. Beck, Marc T. Abrams, Weikang Tao, Rob Lobell, Laura Sepp-Lorenzino, George D. Hartman

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)

Article Chemistry, Medicinal

Optimization of a pyrazoloquinolinone class of Chk1 kinase inhibitors

Edward J. Brnardic, Robert M. Garbaccio, Mark E. Fraley, Edward S. Tasber, Justin T. Steen, Kenneth L. Arrington, Vadim Y. Dudkin, George D. Hartman, Steven M. Stirdivant, Bob A. Drakas, Keith Rickert, Eileen S. Walsh, Kelly Hamilton, Carolyn A. Buser, James Hardwick, Weikang Tao, Stephen C. Beek, Xianzhi Mao, Robert B. Lobell, Laura Sepp-Lorenzino, Youwei Yan, Mari Ikuta, Sanjeev K. Munshi, Lawrence C. Kuo, Constantine Kreatsoulas

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)

Article Chemistry, Medicinal

Comparison of topological, shape, and docking methods in virtual screening

Georgia B. McGaughey, Robert P. Sheridan, Christopher I. Bayly, J. Chris Culberson, Constantine Kreatsoulas, Stacey Lindsley, Vladimir Maiorov, Jean-Francois Truchon, Wendy D. Cornell

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2007)

Article Chemistry, Medicinal

3-(Indol-2-yl)indazoles as Chek1 kinase inhibitors: Optimization of potency and selectivity via substitution at C6

Mark E. Fraley, Justin T. Steen, Edward J. Brnardic, Kenneth L. Arrington, Keith L. Spencer, Barbara A. Hanney, Yuntae Kim, George D. Hartman, Steven M. Stirdivant, Bob A. Drakas, Keith Rickert, Eileen S. Walsh, Kelly Hamilton, Carolyn A. Buser, James Hardwick, Weikang Tao, Stephen C. Beck, Xianzhi Mao, Robert B. Lobell, Laura Sepp-Lorenzino, Youwei Yan, Mari Ikuta, Sanjeev K. Munshi, Lawrence C. Kuo, Constantine Kreatsoulas

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)

Article Chemistry, Medicinal

Development of 6-substituted indolylquinolinones as potent Chek 1 kinase inhibitors

Shaei Huang, Robert M. Garbaccio, Mark E. Fraley, Justin Steen, Constantine Kreatsoulas, George Hartman, Steve Stirdivant, Bob Drakas, Keith Rickert, Eileen Walsh, Kelly Hamilton, Carolyn A. Buser, James Hardwick, Xianzhi Mao, Marc Abrams, Steve Beck, Weikang Tao, Rob Lobell, Laura Sepp-Lorenzino, Youwei Yan, Mari Ikuta, Joan Zugay Murphy, Vinod Sardana, Sanjeev Munshi, Lawrence Kuo, Michael Reilly, Elizabeth Mahan

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)

Article Biochemistry & Molecular Biology

Scoring of KDR kinase inhibitors: Using interaction energy as a guide for ranking

Georgia B. McGaughey, J. Chris Culberson, Bradley P. Feuston, Constantine Kreatsoulas, Vladimir Maiorov, Joseph Shpungin

MOLECULAR DIVERSITY (2006)

Article Chemistry, Medicinal

Design and synthesis of a library of C2-substituted sulfamidoadenosines to probe bacterial permeability

Shibin Zhao, Julian Maceren, Mia Chung, Samantha Stone, Raphael Geiben, Melissa L. Boby, Bradley S. Sherborne, Derek S. Tan

Summary: Antibiotic resistance is a major threat to public health, with Gram-negative bacteria presenting unique challenges due to their low permeability and efflux pumps. Limited understanding of the chemical rules for overcoming these barriers hinders antibacterial drug discovery. Efforts to address this issue, such as screening compound libraries and using cheminformatic analysis, have led to the design of sulfamidoadenosines with diverse substituents, showing potential utility in accumulation in Escherichia coli.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

Design of MERS-CoV entry inhibitory short peptides based on helix-stabilizing strategies

Jichun Li, Qing Li, Shuai Xia, Jiahuang Tu, Longbo Zheng, Qian Wang, Shibo Jiang, Chao Wang

Summary: This study successfully developed a short peptide mimetic as a MERS-CoV fusion inhibitor by reproducing the key recognition features of the HR2 helix. The resulting 23-mer lipopeptide showed comparable inhibitory effect to the 36-mer HR2 peptide HR2P-M2. This has important implications for developing short peptide-based antiviral agents to treat MERS-CoV infection.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

Development of novel β2-adrenergic receptor agonists for the stimulation of glucose uptake - The importance of chirality and ring size of cyclic amines

Krista Jaunsleine, Linda Supe, Jana Spura, Sten van Beek, Anna Sandstrom, Jessica Olsen, Carina Halleskog, Tore Bengtsson, Ilga Mutule, Benjamin Pelcman

Summary: Beta(2)-adrenergic receptor agonists can stimulate glucose uptake by skeletal muscle cells and are therefore potential treatments for type 2 diabetes. The chirality of compounds has a significant impact on the activity of these agonists. This study found that certain synthesized compounds showed higher glucose uptake activity. These findings provide important information for the design of novel beta(2)AR agonists for T2D treatment.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

Conformationally constrained potent inhibitors for enhancer of zeste homolog 2 (EZH2)

Xin Xu, Jia Chen, Guan Wang, Xiaojuan Zhang, Qiang Li, Xiaobo Zhou, Fengying Guo, Min Li

Summary: The study focuses on EZH2, a promising therapeutic target for various types of cancers. Researchers designed and synthesized a series of novel derivatives aiming to enhance the EZH2 inhibition activity. Among them, compound 28 displayed potent EZH2 inhibition activity and showed high anti-proliferative effects in lymphoma cell lines and xenograft mouse models. The study suggests that compound 28 has potential as a therapeutic candidate for EZH2-associated cancers.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

The potential of Rhein's aromatic amines for Parkinson's disease prevention and treatment: α-Synuclein aggregation inhibition and disaggregation of preformed fibers

Wei Zhang, Wei Liu, Ya-Dong Zhao, Li-Zi Xing, Ji Xu, Rui-Jun Li, Yun-Xiao Zhang

Summary: This study developed a series of aromatic amide derivatives based on Rhein and investigated their inhibitory activity against alpha-Syn aggregation. Two of these compounds showed promising potential in treating Parkinson's disease by stabilizing alpha-Syn's conformation and disassembling alpha-Syn oligomers and fibrils.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

Design, synthesis and biological evaluation of novel cationic liposomes loaded with melphalan for the treatment of cancer

Mani Sharma, S. S. S. S. Sudha Ambadipudi, Neeraj Kumar Chouhan, V. Lakshma Nayak, Srihari Pabbaraja, Sai Balaji Andugulapati, Ramakrishna Sistla

Summary: Therapeutically active lipids in drug delivery systems can enhance the safety and efficacy of treatment. The liposome formulation created using synthesized biologically active lipids showed additive anti-cancer effects and reduced tumorigenic potential.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)